Majuven

Summary

Majuven is the famous VC, which was founded in 2011. The company was established in Asia in Singapore. The main office of represented VC is situated in the Singapore.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Singapore. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CrownBio, Eureka Therapeutics, 17 Media. We can highlight the next thriving fund investment areas, such as E-Commerce, Agriculture. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.

The high activity for fund was in 2013. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2016. This Majuven works on 7 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Majuven, startups are often financed by Vertex Ventures Southeast Asia & India, Vertex Ventures, Qiming Venture Partners. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures Southeast Asia & India, Vertex Ventures, Convergence Ventures. In the next rounds fund is usually obtained by YJ Capital, PT Media Nusantara Citra Tbk. (MNC Media Group), K2 Global.